Mark Varvares
Professor and Chair
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (3)
Objective To evaluate the impact of specimen‐based margin (SBM) sampling versus tumor bed‐based margin (TBBM) sampling on adjuvant therapy utilization and local recurrence rates in patients with early‐stage oral cavity squamous cell carcinoma (OCSCC). We hypothesized that TBBM would be associated with increased use of adjuvant treatment and worse local control compared to SBM. Methods In this retrospective, observational study, we reviewed records of patients with cT1 to T2, N0 OCSCC who underwent resection with intraoperative margin assessment at four academic centers between 2000 and 2019. Eligible cases required documentation of the margin sampling technique and at least two years of clinical follow‐up. Local recurrence was the primary outcome, estimated using Aalen–Johansen cumulative incidence functions. Univariable and multivariable Fine–Gray subdistribution hazard models were used to identify associations, accounting for death as a competing risk and clustering by institution. The secondary outcome—adjuvant radiation therapy—was assessed using multivariable logistic regression. Results Among 646 eligible patients, there were no significant differences in reported closest margin distance between techniques. TBBM was associated with a significantly higher likelihood of receiving adjuvant therapy (HR 1.82, 95% CI 1.08–3.05, p = 0.024) and an increased risk of local recurrence (HR 1.72, 95% CI 1.00–2.95, p = 0.049) compared to SBM. Conclusion In early‐stage OCSCC, TBBM is linked to increased adjuvant therapy use and higher local recurrence despite similar margin clearance on final pathology. These findings suggest SBM may offer improved clinical outcomes through more accurate margin assessment. Level of Evidence 3.
Year:
2025
Purpose: The incidence of human papillomavirus (HPV)–associated head and neck squamous cell carcinoma (HPV + HNSCC) is increasing in the United States. Currently, there are no early detection approaches for HPV + HNSCC. Two blood-based analytes for early detection and diagnosis of HPV + HNSCC, circulating tumor HPV DNA (ctHPVDNA) and HPV early protein antibodies (HPV Ab), show promise, yet current approaches lack adequate diagnostic accuracy for broad clinical utility. Further, performance metrics across various assays for detecting these analytes alone or in combination have not been compared head-to-head. To address these limitations and knowledge gaps, we developed a multifeature HPV whole-genome sequencing (WGS) liquid biopsy for improved low-level ctHPVDNA detection. We defined the performance characteristics of this WGS-based approach and compared it head-to-head with existing blood-based HPV detection approaches to determine the optimal single or combinatorial biomarker strategy for a future prospective study of HPV + HNSCC early detection. Experimental Design: We tested blood samples from 304 participants: 152 patients with untreated incident HPV + HNSCC (77% stage I) and 152 general population control patients. We compared WGS-based ctHPVDNA detection, single-plex Droplet Digital PCR (ddPCR)–based ctHPVDNA detection, multiplex ddPCR-based ctHPVDNA detection, multiplex HPV Ab detection, and clinical standard-of-care tissue biopsy, benchmarked to gold-standard HPV + HNSCC tissue diagnosis. We then modeled the operational feasibility of these approaches as screening biomarkers for HPV + HNSCC. Results: HPV WGS sensitivity and specificity were 98.7% and 98.7%, respectively. Single-plex ddPCR sensitivity and specificity were 94.2% and 98.6%, respectively. Multiplex ddPCR sensitivity and specificity were 90.6% and 96.3%, respectively. HPV Ab sensitivity and specificity were 86.4% and 96.3%, respectively. A combinatorial approach using both HPV WGS and HPV Ab yielded a sensitivity and specificity of 87.4% and 98.8%, respectively. In a head-to-head comparison, HPV WGS demonstrated significantly improved diagnostic accuracy compared with ddPCR (Youden index for HPV WGS, 0.99 vs. ddPCR, 0.90; P P P Conclusions: HPV WGS–based ctHPVDNA detection demonstrated the highest sensitivity, specificity, and diagnostic accuracy and thus the lowest number needed to screen and highest positive predictive value compared with ddPCR-based ctHPVDNA detection, HPV Ab–based detection, and combinatorial approaches. These results highlight the promise of HPV WGS liquid biopsy for screening and early detection of HPV + HNSCC and the need for modeling and cost-effectiveness studies to evaluate and guide screening implementation. See related commentary by Haring et al., p. 3359 See related article by Sim et al., p. 3494
Year:
2025
Objective To evaluate for correlation between intraoperative ultrasound (IOUS)‐measured tumor thickness (TT) (uTT) and histopathological TT (hTT), and to compare IOUS‐assisted resection with conventional resection in patients with oral tongue cancers. Data Sources Ovid MEDLINE (1946‐2023), Embase.com (1947‐2023), and Web of Science (All Databases 1900‐2023). Review Methods Inclusion criteria were the use of IOUS for the management of oral tongue cancer. Studies that did not report quantitative data were excluded. Additionally, studies that were not contributory to meta‐analysis, or a narrative analysis of pooled results were excluded. Selection was carried out by 2 reviewers. A total of 2417 studies were initially identified, with 12 ultimately being included in this review, and 7 included in the meta‐analysis. Data were extracted by 2 investigators and were pooled using a random‐effects model. Results Our meta‐analysis reveals a pooled correlation coefficient of 0.92 (95% confidence interval: 0.80‐0.96) for studies comparing uTT to hTT. Studies comparing IOUS‐assisted resection to conventional resection found IOUS‐assisted resection yielded wider nearest margins in all studies reporting this outcome. Conclusion IOUS reliably measures TT, similarly to that of histopathology measurement. IOUS‐assisted resection, which allows the surgeon to view the deep extent of tumor invasion, may increase closest radial margin distance compared to conventional resection. IOUS‐assisted resection may represent a more reliable approach to achieving clear margins than conventional resection.
Year:
2024
Collaborators (10)
Ross Merkin
Attending Physician, Medical Oncology, Center for Head and Neck Cancer
Massachusetts General Hospital
Michael Lawrence
Assistant Professor
Broad Institute
William Faquin
Professor of Pathology
Massachusetts General Hospital
Viktor Adalsteinsson
Group Leader
Broad Institute
Sambit Kumar Mishra
Bioinformatics Scientist
Division of Cancer Epidemiology and Genetics, National Cancer Institute
Andrew Holcomb
Fellow - Head and Neck Oncology
Massachusetts Eye and Ear, Harvard Medical School
Adam Fisch
Assistant in Pathology
Massachusetts General Hospital
Andres Bur
Associate Professor
University of Kansas Medical Center
Allen Feng
Assistant Professor
Harvard Medical School
Peter Sadow
Director, Head & Neck Pathology
Harvard Medical School
Make your next move.
Prepare your application
Review drafts before you send them.